Moderna, Inc. (MRNA)
142.06
-7.60
(-5.08%)
USD |
NASDAQ |
Aug 27, 15:08
Moderna Market Cap : 56.68B for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 59.71B |
| August 25, 2026 | 63.37B |
| August 24, 2026 | 55.42B |
| August 21, 2026 | 57.91B |
| August 20, 2026 | 53.19B |
| August 19, 2026 | 69.58B |
| August 18, 2026 | 25.12B |
| August 17, 2026 | 25.72B |
| August 14, 2026 | 25.26B |
| August 13, 2026 | 25.40B |
| August 12, 2026 | 25.40B |
| August 11, 2026 | 24.17B |
| August 10, 2026 | 23.86B |
| August 07, 2026 | 23.61B |
| August 06, 2026 | 21.49B |
| August 05, 2026 | 22.45B |
| August 04, 2026 | 22.74B |
| August 03, 2026 | 22.00B |
| July 31, 2026 | 21.87B |
| July 30, 2026 | 23.11B |
| July 29, 2026 | 21.74B |
| July 28, 2026 | 22.27B |
| July 27, 2026 | 22.09B |
| July 24, 2026 | 21.47B |
| July 23, 2026 | 22.64B |
| Date | Value |
|---|---|
| July 22, 2026 | 23.05B |
| July 21, 2026 | 23.69B |
| July 20, 2026 | 23.62B |
| July 17, 2026 | 24.54B |
| July 16, 2026 | 25.07B |
| July 15, 2026 | 27.11B |
| July 14, 2026 | 26.77B |
| July 13, 2026 | 26.60B |
| July 10, 2026 | 27.10B |
| July 09, 2026 | 30.39B |
| July 08, 2026 | 29.30B |
| July 07, 2026 | 31.67B |
| July 06, 2026 | 32.47B |
| July 02, 2026 | 31.66B |
| July 01, 2026 | 28.78B |
| June 30, 2026 | 27.80B |
| June 29, 2026 | 27.67B |
| June 26, 2026 | 26.71B |
| June 25, 2026 | 23.72B |
| June 24, 2026 | 23.99B |
| June 23, 2026 | 24.22B |
| June 22, 2026 | 23.56B |
| June 18, 2026 | 25.39B |
| June 17, 2026 | 24.53B |
| June 16, 2026 | 21.99B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioNTech SE | 28.11B |
| Kailera Therapeutics, Inc. | 2.373B |
| Sarepta Therapeutics, Inc. | 2.332B |
| Replimune Group, Inc. | 1.329B |
| Intellia Therapeutics, Inc. | 1.834B |
Market Cap Related Metrics
| PS Ratio | 25.11 |
| PEG Ratio | -2.868 |
| Price to Book Value | 8.384 |
| Price | 142.06 |
| Earnings Yield | -5.62% |
| PEGY Ratio | -2.868 |